Pulse Therapy Ltd 09010200 false 2022-05-01 2023-04-30 2023-04-30 The principal activity of the company is Sports therapy Digita Accounts Production Advanced 6.30.9574.0 true true 09010200 2022-05-01 2023-04-30 09010200 2023-04-30 09010200 bus:Director1 1 2023-04-30 09010200 bus:OrdinaryShareClass1 2023-04-30 09010200 core:CurrentFinancialInstruments 2023-04-30 09010200 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 09010200 core:FurnitureFittingsToolsEquipment 2023-04-30 09010200 core:OtherPropertyPlantEquipment 2023-04-30 09010200 bus:SmallEntities 2022-05-01 2023-04-30 09010200 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 09010200 bus:FullAccounts 2022-05-01 2023-04-30 09010200 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 09010200 bus:RegisteredOffice 2022-05-01 2023-04-30 09010200 bus:Director1 2022-05-01 2023-04-30 09010200 bus:Director1 1 2022-05-01 2023-04-30 09010200 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 09010200 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 09010200 core:FurnitureFittingsToolsEquipment 2022-05-01 2023-04-30 09010200 core:OfficeEquipment 2022-05-01 2023-04-30 09010200 core:OtherPropertyPlantEquipment 2022-05-01 2023-04-30 09010200 core:PlantMachinery 2022-05-01 2023-04-30 09010200 countries:EnglandWales 2022-05-01 2023-04-30 09010200 2022-04-30 09010200 bus:Director1 1 2022-04-30 09010200 core:FurnitureFittingsToolsEquipment 2022-04-30 09010200 core:OtherPropertyPlantEquipment 2022-04-30 09010200 2021-05-01 2022-04-30 09010200 2022-04-30 09010200 bus:Director1 1 2022-04-30 09010200 bus:OrdinaryShareClass1 2022-04-30 09010200 core:CurrentFinancialInstruments 2022-04-30 09010200 core:CurrentFinancialInstruments core:WithinOneYear 2022-04-30 09010200 core:FurnitureFittingsToolsEquipment 2022-04-30 09010200 core:OtherPropertyPlantEquipment 2022-04-30 09010200 bus:Director1 1 2021-05-01 2022-04-30 09010200 bus:Director1 1 2021-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09010200

Pulse Therapy Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2023

 

Pulse Therapy Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

Pulse Therapy Ltd

Company Information

Director

Mr Thomas Ball

Registered office

Jacaranda
Solsbro Road
Torquay
Devon
TQ2 6PF

Accountants

Neil Wilson & Co Chartered Accountant
42a Walnut Road
Chelston
Torquay
Devon
TQ2 6HS

 

Pulse Therapy Ltd

(Registration number: 09010200)
Balance Sheet as at 30 April 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

4,036

4,421

Investments

5

-

25,336

Other financial assets

-

(25,336)

 

4,036

4,421

Current assets

 

Debtors

6

221,225

183,525

Cash at bank and in hand

 

33,329

70,618

 

254,554

254,143

Creditors: Amounts falling due within one year

7

(229,158)

(227,904)

Net current assets

 

25,396

26,239

Net assets

 

29,432

30,660

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

29,332

30,560

Shareholders' funds

 

29,432

30,660

For the financial year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 17 January 2024
 

.........................................
Mr Thomas Ball
Director

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Jacaranda
Solsbro Road
Torquay
Devon
TQ2 6PF

These financial statements were authorised for issue by the director on 17 January 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% Reducing balance

Office equipment

25% Reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 May 2022

3,096

6,103

9,199

Additions

-

961

961

At 30 April 2023

3,096

7,064

10,160

Depreciation

At 1 May 2022

1,502

3,276

4,778

Charge for the year

399

947

1,346

At 30 April 2023

1,901

4,223

6,124

Carrying amount

At 30 April 2023

1,195

2,841

4,036

At 30 April 2022

1,594

2,827

4,421

5

Investments

2023
£

2022
£

Other investments

-

25,336

6

Debtors

Current

Note

2023
£

2022
£

Amounts owed by related parties

10

221,125

183,425

Other debtors

 

100

100

7

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

3,222

3,308

Accruals and deferred income

900

850

Other creditors

225,036

223,746

229,158

227,904

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

8

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

         

9

Dividends

   

2023

 

2022

   

£

 

£

Interim dividend of £40.00 (2022 - £40.00) per ordinary share

 

2,000

 

2,000

         

10

Related party transactions

Transactions with the director

2023

At 1 May 2022
£

Advances to director
£

At 30 April 2023
£

Mr Thomas Ball

loan from director

(223,746)

(1,233)

(224,979)

       
     

 

2022

At 1 May 2021
£

Advances to director
£

Repayments by director
£

At 30 April 2022
£

Mr Thomas Ball

loan from director

4,733

8,384

(236,863)

(223,746)

         
       

 

Director's remuneration

The director's remuneration for the year was as follows:

2023
£

2022
£

Remuneration

10

-

Dividends paid to the director

 

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2023

   

2023
£

 

2022
£

Mr Thomas Ball

       

Interim dividends paid

 

-

 

-